OraSure Technologies Joins the World Coalition on Sickle Cell Disease to Advance Access to Earlier Diagnosis and Care
Key Highlights
- ➤OraSure joins World Coalition on Sickle Cell Disease as newest member
- ➤Coalition collaboration targets earlier diagnosis, screening, and linkage to care
- ➤OraSure will contribute decentralized and point-of-care diagnostics expertise
Expert Statements
John Bannister, Senior Director of International Sales for OraSure
“The value of earlier diagnosis is ultimately measured by what happens next. People need clear pathways to appropriate care, supported by trained healthcare workers, effective referral systems, sustainable funding, and access to ongoing treatment. We are proud to join the World Coalition on Sickle Cell Disease and work alongside people living with sickle cell disease and the broader community to help strengthen the connections between diagnosis and care.”
Mario Ottiglio, Secretariat Lead for the World Coalition on Sickle Cell Disease
“We’re excited to welcome OraSure Technologies as the newest member of the Coalition. Their diagnostics expertise will be a valuable addition to our collective efforts, helping advance timely and appropriate diagnosis that connects people to treatment, care, and long-term support.”
BETHLEHEM, Pa., Nov. 02, 2026 (GLOBE NEWSWIRE) -- OraSure Technologies, Inc., a global leader in point-of-care and home diagnostic tests and sample management solutions, announced today that it has joined the World Coalition on Sickle Cell Disease, an international public-private partnership working to strengthen the global response to sickle cell disease.
The Coalition brings together stakeholders from across patient advocacy, government, healthcare, research, international institutions, civil society, and the private sector. Its work seeks to elevate sickle cell disease on the global health agenda, strengthen care for people living with the condition, and help countries translate policy commitments into improved services and outcomes.
Get started
Create a free account to read the full story.